Patient-Reported Outcomes After Neoadjuvant Atezolizumab–Chemotherapy in Early TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
NPJ breast cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Patient-reported outcomes from a randomized trial of neoadjuvant atezolizumab-chemotherapy in early triple-negative breast cancer
NPJ Breast Cancer 2022 Sep 19;8(1)108, CH Barrios, S Saji, N Harbeck, H Zhang, KH Jung, S Patel, S Patel, AN Duc, M Liste-Hermoso, SY Chui, EA MittendorfFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.